October 26, 2016 5:13 PM ET


Company Overview of Tetragenex Pharmaceuticals, Inc.

Company Overview

Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The company’s principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. It also develops other central nervous systems active peptides, as second-generation medications for the treatment of depression, anxiety, and other psychiatric disorders. The company is headquartered in Syosset, New York.

6901 Jericho Turnpike

Suite 221

Syosset, NY 11791

United States

2 Employees


516-855 4425

Key Executives for Tetragenex Pharmaceuticals, Inc.

Chairman of the Board and Co-Chief Executive Officer
Age: 59
Vice Chairman, Co-Chief Executive Officer, Treasurer and Member of Compensation Committee
Age: 73
Chief Operating Officer and Director
Age: 74
Chief Scientific Officer, Senior Vice President of Drug Development & Regulatory Affairs and Director
Age: 81
Vice President of Operations and Secretary
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tetragenex Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.